Leaving behind a successful and enjoyable practice after 15 years is not a decision made lightly, but it is one I have made wholeheartedly. During the decision-making process, I observed the strong foundation that existed in the UCSF Department of Orthopaedic Surgery and saw the promise of exciting future growth. There is an expectation at UCSF that the quality of care, the basic and clinical research, and the educational experience must both meet the needs of our patients and have an international impact.
As the longstanding chairman, Dr. David Bradford was a visionary who accomplished amazing things during his tenure. Building on that platform of success, we will put an emphasis on education, delivery of care and clinical outcomes, and both basic and translational research. The time is ripe for cross-pollination of our work with creative research teams in other centers such as the Institute for Regeneration Medicine and the Institute for Health Policy Studies.
A centerpiece of our future will be the development of an orthopaedics institute. In the future, our department will work from an institute that is created for optimal delivery of musculoskeletal care. The institute will provide the elements necessary for the convenience of the patient and for the clinician to improve both efficiency and effectiveness.
What does all of this mean for alumni, referring physicians and patients? There are many reasons to have pride in UCSF and to come to UCSF. The most important reason is that we are able to meet the needs of the people we serve. The greatest compliment that people can give is to entrust their care to us. We want to be the place that people choose.
Thomas Parker Vail, M.D.
Professor and Chair
Department of Orthopaedic Surgery
Annual Drug Dose Cuts Bone Fractures
A treatment for osteoporosis delivered once a year is as effective as current monthly or weekly osteoporosis regimens to reduce bone fractures, according to a new study led by a UCSF research team.
Cost of Treating Arthritis on Rise, Study Shows
The amount Americans spent on arthritis medications more than doubled from 1998 to 2003, due to an increase in those with the disease as well as increases in the number of medications they take and the cost per prescription, according to a study led by a UCSF researcher.